Beam Therapeutics (NASDAQ:BEAM) outlined a new liver-targeted development program for phenylketonuria (PKU) and announced a large, non-dilutive financing tied to its sickle cell disease launch plans ...

Take your images to the next level with the best photo editing software. Jon Stapley and the AP team pick top programs, ...

New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for BEAM‑304 Anticipated in 2026 ...

Masters runners Deena Kastor, Knox Robinson, and Chris Twiggs share the lessons that helped them keep running strong after 50 ...

The Times spoke to three of the most viewed Spanish-language educators for children on YouTube to see what goes behind ...

Financing Bolsters Balance Sheet with Long-term, Non-dilutive Capital to Support Anticipated Launch of Risto-cel in Sickle Cell Disease (SCD) ...

Zendocs is redefining document management with a fast, browser-based platform that enables users to edit, convert, and manage ...

Wisconsin DNR awards brownfield assessment services to help Marathon City investigate contamination at the former ...

By Tom Westbrook SINGAPORE, Feb 24 (Reuters) - An imagined dystopia of mass unemployment fuelled by artificial intelligence, ...

I appreciated VTDigger’s recent article on Vermont’s consideration of joining the ArrayRx prescription discount card program. Efforts to make medications more affordable are i ...

Roy Wood Jr. doesn't sound like Jake Tapper, Anderson Cooper or Erin Burnett. And yet, his importance to CNN could start ...

Warner Bros. Discovery says it's reviewing a new takeover offer from Paramount, but it continues to recommend a competing ...